Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 3
2010 2
2011 4
2012 6
2013 5
2014 9
2015 10
2016 10
2017 6
2018 8
2019 17
2020 10
2021 15
2022 9
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Endothelial Dysfunction in Diabetes.
Takeda Y, Matoba K, Sekiguchi K, Nagai Y, Yokota T, Utsunomiya K, Nishimura R. Takeda Y, et al. Biomedicines. 2020 Jun 29;8(7):182. doi: 10.3390/biomedicines8070182. Biomedicines. 2020. PMID: 32610588 Free PMC article. Review.
ROCK2-induced metabolic rewiring in diabetic podocytopathy.
Matoba K, Takeda Y, Nagai Y, Sekiguchi K, Ukichi R, Takahashi H, Aizawa D, Ikegami M, Tachibana T, Kawanami D, Kanazawa Y, Yokota T, Utsunomiya K, Nishimura R. Matoba K, et al. Among authors: takeda y. Commun Biol. 2022 Apr 8;5(1):341. doi: 10.1038/s42003-022-03300-4. Commun Biol. 2022. PMID: 35396346 Free PMC article.
ROCK Inhibition May Stop Diabetic Kidney Disease.
Matoba K, Takeda Y, Nagai Y, Kanazawa Y, Kawanami D, Yokota T, Utsunomiya K, Nishimura R. Matoba K, et al. Among authors: takeda y. JMA J. 2020 Jul 15;3(3):154-163. doi: 10.31662/jmaj.2020-0014. Epub 2020 Jun 19. JMA J. 2020. PMID: 33150249 Free PMC article. Review.
Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis.
Isshiki Y, Oshima M, Mimura N, Kayamori K, Miyamoto-Nagai Y, Seki M, Nakajima-Takagi Y, Kanamori T, Iwamoto E, Muto T, Tsukamoto S, Takeda Y, Ohwada C, Misawa S, Ikeda JI, Sanada M, Kuwabara S, Suzuki Y, Sakaida E, Nakaseko C, Iwama A. Isshiki Y, et al. Among authors: takeda y. JCI Insight. 2022 Oct 24;7(20):e151482. doi: 10.1172/jci.insight.151482. JCI Insight. 2022. PMID: 36129760 Free PMC article.
Single-cell transcriptomics identifies adipose tissue CD271+ progenitors for enhanced angiogenesis in limb ischemia.
Inoue O, Goten C, Hashimuko D, Yamaguchi K, Takeda Y, Nomura A, Ootsuji H, Takashima S, Iino K, Takemura H, Halurkar M, Lim HW, Hwa V, Sanchez-Gurmaches J, Usui S, Takamura M. Inoue O, et al. Among authors: takeda y. Cell Rep Med. 2023 Dec 19;4(12):101337. doi: 10.1016/j.xcrm.2023.101337. Cell Rep Med. 2023. PMID: 38118404 Free PMC article.
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.
Kawanami D, Matoba K, Takeda Y, Nagai Y, Akamine T, Yokota T, Sango K, Utsunomiya K. Kawanami D, et al. Among authors: takeda y. Int J Mol Sci. 2017 May 18;18(5):1083. doi: 10.3390/ijms18051083. Int J Mol Sci. 2017. PMID: 28524098 Free PMC article. Review.
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.
Shibamiya A, Miyamoto-Nagai Y, Koide S, Oshima M, Rizq O, Aoyama K, Nakajima-Takagi Y, Kato R, Kayamori K, Isshiki Y, Oshima-Hasegawa N, Muto T, Tsukamoto S, Takeda Y, Koyama-Nasu R, Chiba T, Honda H, Yokote K, Iwama A, Sakaida E, Mimura N. Shibamiya A, et al. Among authors: takeda y. Cancer Immunol Immunother. 2023 Aug;72(8):2635-2648. doi: 10.1007/s00262-023-03447-x. Epub 2023 Apr 17. Cancer Immunol Immunother. 2023. PMID: 37069353
107 results